Literature DB >> 1247393

Immunoglobulin abnormalities and measles antibody response in chronic myelopathy.

H Link, E Norrby, J E Olsson.   

Abstract

Patients with chronic myelopathy of unknown origin were separated into two groups on the basis of presence or absence of oligoclonal immunoglobulin G (lgG) in cerebrospinal fluid (CSF). Thirty-nine of 48 patients (81%) with oligoclonal lgG in CSF had measles virus antibodies in the CSF and 31 (65%) showed reduced serum/CSF measles virus antibody ratios, in comparison with the corresponding ratios of adenovirus, group-specific, penton hemagglutination-enhancement and poliovirus neutralization-enhancement antibodies. Of 25 patients with myelopathy, but without oligoclonal lgG in their CSF, three had detectable titers of measles CSF antibodies and one of these had a greatly reduced serum/CSF ratio. The conditions of patients with chronic myelopathy of unknown origin and oligoclonal lgG in CSF may be diagnosed as probable multiple sclerosis (MS), in contrast to patients with this disease who lack oligoclonal lgG IN CSF. However, the clinical features of the disease in these two groups do not differ substantially.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247393     DOI: 10.1001/archneur.1976.00500010028005

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Chronic, relapsing myelitis in hamsters associated with experimental measles virus infection.

Authors:  D R Carrigan; K P Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

2.  Detecting immunoglobulin abnormalities in the cerebrospinal fluid (CSF): which methods are best for clinical purposes?

Authors:  M A Laurenzi; L Provinciali; A R Giovagnoli; V Busco Bocchini; L Paris; F Chiodi
Journal:  Ital J Neurol Sci       Date:  1987-06

3.  Relationship between measles virus-specific antibody activities and oligoclonal IgG in the central nervous system of patients with subacute sclerosing panencephalitis and multiple sclerosis.

Authors:  E Norrby; B Vandvik
Journal:  Med Microbiol Immunol       Date:  1975-12-30       Impact factor: 3.402

4.  Severe demyelinating diseases in childhood: a clinicopathological study.

Authors:  J M Adams
Journal:  J Natl Med Assoc       Date:  1978-03       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.